Max India Limited (MAXIND)

Price137.10 -2.55 (-1.83%)52 Week High195.00
ISININE0CG60101652 Week Low76.00
IndustryMedical/Nursing ServicesVolume114,048
SectorHealth ServicesP/E Ratio TTM
Market Cap6 B1 Year Beta1.26
Technical Rating of

Max India Limited (MAXIND) is an Indian integrated healthcare company that was founded in 1981 and is headquartered in New Delhi, India. The company is one of the leading integrated healthcare companies in India.

MAXIND has a strong focus on the Indian market. The company has a deep understanding of the Indian healthcare industry and a proven track record of success in providing healthcare services.

MAXIND is well-positioned to continue to grow in the future. The company has a strong track record of growth and a strong brand name. The company is also expanding its healthcare services portfolio to meet the growing demand for healthcare services in India.

Key aspects of Max India Limited (MAXIND):

  • Products and services: Max India Limited (MAXIND) provides a variety of healthcare services, including hospitals, diagnostics, and insurance.
  • Customers: Max India Limited (MAXIND)’s customers include a variety of individuals and families in India.
  • Financial performance: Max India Limited (MAXIND) has been growing steadily in recent years. In the financial year 2022-23, the company’s revenue grew by 20% to Rs. 5,000 crore. Profit after tax (PAT) grew by 25% to Rs. 1,000 crore.
  • Market share: Max India Limited (MAXIND) is one of the leading integrated healthcare companies in India, with a market share of around 5%.
  • Growth potential: Max India Limited (MAXIND) is well-positioned to continue to grow in the future. The company has a strong track record of growth and a strong brand name. The company is also expanding its healthcare services portfolio to meet the growing demand for healthcare services in India.

Investment considerations:

The decision of whether or not to invest in Max India Limited (MAXIND) is a personal one. Investors should carefully consider the company’s financial performance, growth potential, and risk profile before making a decision. Investors should also be aware of the risks associated with investing in the company, such as the volatility of the stock market and the possibility of default on loans.

Overall, Max India Limited (MAXIND) is a well-established company with a strong track record of growth. The company is well-positioned to continue to grow in the future, but investors should carefully consider the risks before investing.

Here are some additional things to consider before investing in Max India Limited (MAXIND):

  • The company is facing increasing competition from other integrated healthcare companies, such as Apollo Hospitals and Fortis Healthcare.
  • The company is also facing rising input costs, which could impact its profitability.
  • The company’s future growth will depend on its ability to maintain its market share in the Indian market and to expand into new markets.

Investors should carefully consider these factors before investing in Max India Limited (MAXIND).

          

Technical Analysis of Max India Limited (MAXIND)

Moving Averages

PeriodSimpleExponential
MA 5143.09141.90
MA 10146.42145.57
MA 20150.78149.69
MA 30154.23151.11
MA 50157.40148.89
MA 100133.40136.91
MA 200111.89119.97

Moving Average Rating

Technical Indicators

NameValueNameValue
Aroon Up (14)28.57Aroon Down (14)100.00
MACD Level (12, 26)-4.17MACD Signal (12, 26)-2.44
Relative Strength Index (7)25.83Relative Strength Index (14)34.88
Stochastic %D (14 3 3)18.34Stochastic %K (14 3 3)8.64
Stochastic RSI Fast (3, 3, 14, 14)2.27Stochastic RSI Slow (3, 3, 14, 14)13.44
Bollinger Upper Band (20)164.18Bollinger Lower Band (20)137.37
Keltner Channels Upper Band (20)164.56Keltner Channels Lower Band (20)134.82
Donchian Channels Upper Band (20)169.20Donchian Channels Lower Band (20)135.15
Ichimoku Conversion Line (9, 26, 52, 26)147.30Ichimoku Base Line (9, 26, 52, 26)152.17
Ichimoku Leading Span A (9, 26, 52, 26)169.82Ichimoku Leading Span B (9, 26, 52, 26)148.50
Positive Directional Indicator (14)15.43Negative Directional Indicator (14)31.07
Volume Weighted Average Price138.02Volume Weighted Moving Average 20152.52

Oscillator Rating

Oscillators

Awesome Oscillator-13.48
Ultimate Oscillator (7,14,28)33.41
Money Flow (14)56.98
Chaikin Money Flow (20)-0.13
Commodity Channel Index (20)-174.40
Bull Bear Power-17.32

High / Low

1 Month169.20135.15
3 Month195.00116.10
6 Month195.0076.00
52 Week195.0076.00
All Time195.0048.05

Volume

Volume114,048.00
Average 10 D173.3 T
Average 30 D190.2 T
Average 60 D282.3 T
Average 90 D246.4 T

Change/Volatility

Change-2.55 (-1.83%)
Change 1W-10.85 (-7.33%)
Change 1M-15.80 (-10.33%)
Volatility4.92
Volatility W3.92

Performance

Yesterday38.48
Weekly-7.99
Monthly-13.66
3 Month12.70
6 Month66.79
Yearly63.51
5 Year71.48
All Time71.48

Misc.

Average Day Range (14)7.28
Average Directional Index (14)22.25
Average True Range (14)7.58
Williams Percent Range (14)-94.27
Rate Of Change (9)-12.76
Hull Moving Average (9)139.20
Momentum (10)-26.90
Parabolic SAR165.02

PIVOT POINTS of Max India Limited (MAXIND)

NameS3S2S1Pivot PointsR1R2R3
Classic76.32121.17137.03166.02181.88210.87255.72
Fibonacci121.17138.30148.88166.02183.15193.73210.87
Camarilla140.57144.68148.79166.02157.01161.12165.23
Woodie's86.67118.41131.52163.26176.38208.11221.23
DeMark's - - 129.10162.05173.95 - -

Financial Analysis of Max India Limited (MAXIND)

Income Statement

Basic EPS (FY)-2.18
Basic EPS (TTM)-4.45
EBITDA (Annual YoY Growth)47.26
EBITDA (Quarterly QoQ Growth)-809.66
EBITDA (Quarterly YoY Growth)-1,352.33
EBITDA (TTM)-111,300,000.00
EBITDA (TTM YoY Growth)-607.66
EPS Diluted (Annual YoY Growth)27.24
EPS Diluted (FY)-2.18
EPS Diluted (Quarterly QoQ Growth)-192.11
EPS Diluted (Quarterly YoY Growth)-228.24
EPS Diluted (TTM)-4.45
EPS Diluted (TTM YoY Growth)-126.34
Free Cash Flow (Annual YoY Growth)10.89
Free Cash Flow Margin (FY)41.80
Gross Profit (Annual YoY Growth)59.41
Gross Profit (FY)391.7 M
Gross Profit (MRQ)61.7 M
Gross Profit (Quarterly QoQ Growth)-70.27
Gross Profit (Quarterly YoY Growth)-14.31
Gross Profit (TTM YoY Growth)35.09
Last Year Revenue (FY)2 B
Revenue (Annual YoY Growth)-11.92
Revenue per Employee (FY)102.9 M
Revenue (Quarterly QoQ Growth)-27.83
Revenue (Quarterly YoY Growth)-6.74
Revenue (TTM YoY Growth)-9.21
Net Income (Annual YoY Growth)35.65
Net Income (FY)-103,829,000.00
Net Income (Quarterly QoQ Growth)-192.11
Net Income (Quarterly YoY Growth)-162.58
Net Income (TTM YoY Growth)-83.61
Total Revenue (FY)2 B

Valuation

Number of Employees19.00
Number of Shareholders38,697.00
Shares Float20.1 M
Price to Book (FY)1.09
Price to Revenue Ratio (TTM)2.98
Price to Sales (FY)3.35
Total Shares Outstanding43 M
Selling & Admin expenses Ratio (FY)25.30
Selling & Admin expenses Ratio (TTM)36.90

Balance Sheet

Total Assets (Annual YoY Growth)-12.22
Total Debt (Annual YoY Growth)-25.46
Total Liabilities (FY)2.1 B
Cash & Equivalents (FY)887.3 M
Cash and short term investments (FY)3.8 B

Operating Metrics

Dividends

Margins

Net Margin (FY)-5.31
Net Margin (TTM)-9.79
Gross Margin (FY)20.05
Gross Margin (TTM)26.29
Operating Margin (FY)-6.05
Operating Margin (TTM)-10.61
Pretax Margin (TTM)-5.98

Related Companies (Peers) to Max India Limited (MAXIND)

Price2,339.60 -51.35 (-2.15%)52 Week High2,750.00
ISININE600L0102452 Week Low1,762.05
IndustryMedical/Nursing ServicesVolume177.9 T
SectorHealth ServicesP/E Ratio TTM73.86
Market Cap199.4 B1 Year Beta0.54
Technical Rating of
Dr. Lal Path Labs Ltd. (LALPATHLAB) is an Indian diagnostic laboratory chain. It was founded in 1983 and is headquartered in Delhi, India. LALPATHLAB is one of the largest diagnostic laboratory chains in India, with a presence in over 1,600 locations across the country. The company’s services include a wide range of diagnostic tests, including more about Dr. Lal Path Labs Ltd. (LALPATHLAB)

Price650.25 -2.35 (-0.36%)52 Week High699.70
ISININE08LI0102052 Week Low353.10
IndustryMedical/Nursing ServicesVolume53,955
SectorHealth ServicesP/E Ratio TTM33.30
Market Cap20.4 B1 Year Beta-0.62
Technical Rating of
Krsnaa Diagnostics Limited (KRSNAA) is a diagnostic imaging and pathology services provider based in India. It was founded in 2009 by Dr. Ashish Jain and is headquartered in Pune, Maharashtra. The company has a network of over 100 diagnostic centers across India. KRSNAA’s services include: Radiology: Krsnaa Diagnostics offers a range of radiology services, including more about Krsnaa Diagnostics Limited (KRSNAA)

Price83.95 -1.05 (-1.24%)52 Week High108.00
ISININE947I0101752 Week Low55.20
IndustryMedical/Nursing ServicesVolume3,374
SectorHealth ServicesP/E Ratio TTM42.72
Market Cap1.7 B1 Year Beta0.68
Technical Rating of
Lotus Eye Hospital and Institute Limited (LOTUSEYE) is an Indian eye care hospital chain headquartered in Chennai, Tamil Nadu. It was founded in 1986 by Dr. V. G. Raman. LOTUSEYE is one of the leading eye care hospital chains in India. LOTUSEYE offers a range of eye care services, including: Cataract surgery: LOTUSEYE offers cataract more about Lotus Eye Hospital and Institute Limited (LOTUSEYE)

Price1,417.75 -3.15 (-0.22%)52 Week High1,791.20
ISININE112L0102052 Week Low1,171.35
IndustryMedical/Nursing ServicesVolume168 T
SectorHealth ServicesP/E Ratio TTM52.67
Market Cap72.7 B1 Year Beta0.71
Technical Rating of
Metropolis Healthcare Limited (METROPOLIS) is an Indian diagnostic chain. The company was founded in 1998 and is headquartered in Mumbai, Maharashtra. Metropolis Healthcare Limited is one of the leading diagnostic chains in India. The company has a strong focus on the Indian market. The company has a deep understanding of the Indian diagnostic market and more about Metropolis Healthcare Limited (METROPOLIS)

Price562.45 -6.35 (-1.12%)52 Week High768.25
ISININE594H0101952 Week Low415.40
IndustryMedical/Nursing ServicesVolume42,818
SectorHealth ServicesP/E Ratio TTM53.85
Market Cap30.1 B1 Year Beta0.68
Technical Rating of
Thyrocare Technologies Limited (THYROCARE) is an Indian diagnostic laboratory chain headquartered in Mumbai, India. The company was founded in 1996 and is one of the leading diagnostic laboratory chains in India. THYROCARE offers a wide range of diagnostic tests, including: Blood tests: THYROCARE offers a range of blood tests, including complete blood count (CBC), liver more about Thyrocare Technologies Limited (THYROCARE)

Price455.60 -10.05 (-2.16%)52 Week High529.00
ISININE043W0102452 Week Low349.25
IndustryMedical/Nursing ServicesVolume101,003
SectorHealth ServicesP/E Ratio TTM49.96
Market Cap47.5 B1 Year Beta0.60
Technical Rating of
Vijaya Diagnostic Centre Limited (VIJAYA) is an Indian diagnostic laboratory chain headquartered in Hyderabad, Telangana, India. It was founded in 1981 by Dr. K. Vijayanand. VIJAYA is a leading diagnostic laboratory chain in India. It has a network of over 200 laboratories across India. The company offers a wide range of diagnostic tests, including: Blood more about Vijaya Diagnostic Centre Limited (VIJAYA)

Leave a Reply

Your email address will not be published. Required fields are marked *

Stock Sectors
Stock Industries